Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bruker Corp (NQ: BRKR )

59.29 +2.68 (+4.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bruker Corp

< Previous 1 2 3 4 5 6 7 8 9 Next >
Bruker Corporation to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
From Bruker Corporation
Via Business Wire
Bruker Enters Functional Single-Cell Biology Research Solutions With PhenomeX Acquisition
Bruker Corporation (NASDAQ: BRKR) has agreed to acquire PhenomeX Inc (NASDAQ: CELL) for $1.00 per share in an  
Via Benzinga
Health Care Company Bruker Announces Acquisition of PhenomeX
Via Benzinga
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
From Bruker Corporation
Via Business Wire
Recap: Bruker Q1 Earnings
Via Benzinga
Bruker's Earnings: A Preview
Via Benzinga
Bruker to Provide 60 Explosives Trace Detectors for Zuerich Airport
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker Reports Second Quarter 2023 Financial Results
From Bruker Corporation
Via Business Wire
The Fed's Influence Ripples Through US Stocks, ETFs: Wednesday's Winners And Losers Revealed
Via Benzinga
Bruker Announces Date and Time of Second Quarter 2023 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries
From Bruker Corporation
Via Business Wire
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
From Bruker Corporation
Via Business Wire
Bruker Announces New D6 PHASERTM Benchtop X-Ray Diffraction (XRD) Platform for Materials Analysis and Advanced Research
From Bruker Corporation
Via Business Wire
Bruker Releases 2023 Sustainability Report
From Bruker Corporation
Via Business Wire
Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™
From Bruker Corporation
Via Business Wire
PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS
From Bruker Corporation
Via Business Wire
Bruker Introduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments
From Bruker Corporation
Via Business Wire
Bruker Corporation to Present at Jefferies 2023 Healthcare Conference
From Bruker Corporation
Via Business Wire
Bruker to Host Investor Day on June 15th, 2023
From Bruker Corporation
Via Business Wire
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker Reports First Quarter 2023 Financial Results
From Bruker Corporation
Via Business Wire
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
From Bruker Corporation
Via Business Wire
PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
From Bruker Corporation
Via Business Wire
Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
From Bruker Corporation
Via Business Wire
Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
From Bruker Corporation
Via Business Wire
Shockwave Medical Stock With Rising Relative Strength
On Tuesday, Shockwave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 67 to 75. 
Via Investor's Business Daily
The 3 Most Promising Biotech Stocks to Buy Now
With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.